Search

Author/Creator Carpenter, Nancy

1. A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents. Issue 7 (1st April 2016)

Authors:
Mathias, Susan D.; Li, Xiaoyan; Eisen, Melissa; Carpenter, Nancy; Crosby, Ross D.; Blanchette, Victor S.
Journal:
Pediatric blood & cancer
Issue:
Volume 63:Issue 7(2016)
Page Start:
1232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. Issue 3 (March 2018)

Authors:
Kantarjian, Hagop M; Fenaux, Pierre; Sekeres, Mikkael A; Szer, Jeffrey; Platzbecker, Uwe; Kuendgen, Andrea; Gaidano, Gianluca; Wiktor-Jedrzejczak, Wieslaw; Carpenter, Nancy; Mehta, Bhakti; Franklin, Janet; Giagounidis, Aristoteles
Journal:
Lancet
Issue:
Volume 5:Issue 3(2018)
Page Start:
e117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Issue 10039 (2nd July 2016)

Authors:
Tarantino, Michael D; Bussel, James B; Blanchette, Victor S; Despotovic, Jenny; Bennett, Carolyn; Raj, Ashok; Williams, Bronwyn; Beam, Donald; Morales, Jaime; Rose, Melissa J; Carpenter, Nancy; Nie, Kun; Eisen, Melissa
Journal:
Lancet
Issue:
Volume 388:Issue 10039(2016)
Page Start:
45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗